Zamudio LI, Pastrana ZAA, Ridaura VC, Amaral VD, Rodríguez POM, Serrano LR, Guerrero AGML

Language: Spanish
References: 21
Page: 151-159
PDF size: 291.51 Kb.

ABSTRACT

In May 2022, several countries where monkeypox was not endemic reported cases constituting a public health emergency of international importance. As of March 2023, the World Health Organization reports 86 514 cases, of which more than half correspond to the region of the Americas, and Mexico ranks 4th with 3 928.
Objective. To present the epidemiological behavior of Mpox in a tertiary public hospital and the local behavior of positive cases.
Material and Methods. A cross-sectional, analytical study of probable Mpox cases was carried out. A descriptive analysis of: frequencies and proportions and Mantel and Haenszel chi-square.
Results. A total of 60 probable cases of which 54 were positive, regarding sexual preference, 74% of the hospital cases were men who had sex with men (MSM) and to a lesser extent bisexual and gay, compared to national behavior, gays occupied a higher proportion. The first clinical data most frequently presented by the patients was rash in the pelvic genital and/or perianal region accompanied or not by fever, there was no major difference in the behavior of the rash and the presence of HIV. Although there is a definition of a case where there is a prodrome and later the presence of a rash, the confirmed cases presented important variants, so it is important to consider them in order to promptly determine a probable case and apply measures to prevent complications and community spread.

REFERENCES

1. Organización Panamericana de la Salud-OrganizaciónMundial de la Salud, Alerta epidemiológica: “Viruelasímica en países no endémicos”, 20 de mayo de 2022,Washington, ops-oms, 2022.

2. Gobierno de México, Sistema Nacional de VigilanciaEpidemiológica, Comité Nacional para la Vigilancia Epidemiológica,“Aviso epidemiológico”, Conave, marzo de2022, viruela símica 24 de mayo de 2022.

3. Organización Panamericana de la Salud-OrganizaciónMundial de la Salud, “Viruela símica”, ops-oms, revisadoel 11 de marzo de 2023. Disponible en: https://www.paho.org/es/brote-por-enfermedad-viruela-simica-2022.

4. Magariños, M. y Rey, G., “Recomendaciones para lavacunación contra Mpox, situación de los países de laregión”, ops, 3 de marzo de 2023. Disponible en: https://www.paho.org.

5. “Reporte mundial de Mpox al 13 de marzo 2023”, revisadoel 11 de marzo de 2023. Disponible en: https://shiny.pahobra.org/Mpox/.

6. “La oms recomienda un nuevo nombre para la viruelasímica”, revisado el 14 de marzo de 2023. Disponibleen:https://www.paho.org/es/noticias/28-11-2022-oms-recomienda-nuevo-nombre-paraviruelasimica#:~:text=Ginebra%20(Suiza)%2C%2028%20de,viruela%20s%C3%ADmica%E2%80%9D%20en%20espa%C3%-B1ol).

7. Vera Villamar, R.A., Orellana Barros, M.R., Orellana Tapia,B.A. et al., “Viruela símica: revisión bibliográfica”,Más Vita, 2022, 4 (2), 77-85.

8. Secretaría de Salud, Dirección General de Epidemiología,Subsecretaría de Prevención y Promoción de laSalud, “Informe Técnico quincenal de vigilancia epidemiológicade Mpox (antes viruela símica) en México”,7de febrero de 2023. Disponible en: https://www.gob.mx/salud/documentos/informes-quincenales-para-la-vigilancia-epidemiologica-de-viruela-simica-en-mexico.

9. Adler, H., Gould, S., Hine, P., Snell, L.B., Wong, W.,Houlihan, C.F. et al., “nhs England high consequence1.infectious diseases (airborne) network. Clinical featuresand management of human monkeypox: a retrospectiveobservational study in the UK”, Lancet InfectDis, 2022, 22 (8): 1153-1162.

10. Petersen, E., Abubakar, I., Ihekweazu, C. et al.,“Monkeypox: enhancing public health preparednessfor an emerging lethal human zoonotic epidemic threatin the wake of the smallpox post-eradication era”, Int JInfect Dis, 2019, 78: 78-84.

11. Nolen, L.D., Osadebe, L., Katomba, J. et al., “Introductionof Monkeypox into a community and household:risk factors and zoonotic reservoirs in the DemocraticRepublic of the Congo”, Am J Trop Med Hyg, 2015, 93(2): 410-415.

12. Sah, R., Mohanty, A., Hada, V., Singh, P., Govindaswamy,A., Siddiq, A. et al., “The emergence of monkeypox: aglobal health threat”, Cureus, 2022, 14 (9): e29304.

13. Rimoin, A.W., Mulembakani, P.M., Johnston, S.C. etal., “Major increase in human monkeypox incidence 30years after smallpox vaccination campaigns cease inthe Democratic Republic of Congo”, Proc Natl Acad SciUSA, 2010, 107 (37): 16262-16267.

14. Khodakevich, L., Szczeniowski, M., Nambu-ma-Disu etal., “Monkeypox virus in relation to the ecological featuressurrounding human settlements in Bumba zone,Zaire”, Trop Geogr Med, 1987, 39 (1): 56-63.

15. Harapan, H., Ophinni, Y., Megawati, D., Frediansyah, A.et al., “Monkeypox: a comprehensive review”, Viruses,2022, 14 (10): 2155.

16. Rimoin, A.W., Kisalu, N.K., Kebela-Ilunga, B., Mukaba, T.et al., “Endemic human monkeypox, Democratic Republicof Congo, 2001-2004”, Emerging Infectious Diseases,2007, 13 (6): 934-937.

17. Elsayed, S., Bondy, L. y Hanage W.P., “Monkeypox virusinfections in humans”, Clin Microbiol Rev, 2022, 35 (4):e0009222.

18. Acha, P.N. y Szyfres, B., “Zoonoses and communicablediseases common to man and animals”, Parasitoses,vol. iii, Pan American Health Organization, 2020.

19. Likos, A.M., Sammons, S.A., Olson, V.A., Frace et al., “Atale of two clades: monkeypox viruses”, J General Virol,

20. 2005, 86 (10): 2661-2672.20. Reynolds, M.G., Carroll, D.S., Olson, V.A. et al., “A silentenzootic of an orthopoxvirus in Ghana, West Africa:evidence for multi-species involvement in the absenceof widespread human disease”, Am J Trop Med Hyg,2010, 82 (4): 746-754.

21. Petersen, E., Kantele, A., Koopmans, M., Asogun, D.,Yinka-Ogunleye, A., Ihekweazu, C. y Zumla, A., “Humanmonkeypox: epidemiologic and clinical characteristics,diagnosis, and prevention”, Infect Dis Clin North Am,2019, 33 (4): 1027-1043.